Lee, Youngmin A.
Noon, Luke A.
Akat, Kemal M.
Ybanez, Maria D.
Lee, Ting-Fang
Berres, Marie-Luise
Fujiwara, Naoto
Goossens, Nicolas
Chou, Hsin-I
Parvin-Nejad, Fatemeh P.
Khambu, Bilon
Kramer, Elisabeth G. M.
Gordon, Ronald
Pfleger, Cathie
Germain, Doris
John, Gareth R.
Campbell, Kirk N.
Yue, Zhenyu
Yin, Xiao-Ming
Cuervo, Ana Maria https://orcid.org/0000-0002-0771-700X
Czaja, Mark J.
Fiel, M. Isabel
Hoshida, Yujin https://orcid.org/0000-0001-9430-1426
Friedman, Scott L. https://orcid.org/0000-0003-1178-6195
Article History
Received: 9 October 2015
Accepted: 19 October 2018
First Online: 23 November 2018
Competing interests
: The authors declare the following competing interests: A.M.C. is co-founder of Selphagy Therapeutics (Boston) and consults for Neuropore (San Diego, CA). S.L.F. was consultant to Vivace Therapeutics. The remaining authors declare no competing interests.